Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Fernández-Ruiz

Showing results (1-10 of 156) with videos related to

Pageof 16
Sort By:
British Journal of Pharmacology|February 18, 2009
The endocannabinoid system as a target for the treatment of motor dysfunctionJavier Fernández-Ruiz
Revista De Neurologia|May 11, 2012
[Cannabinoid drugs for neurological diseases: what is behind?]Javier Fernández-Ruiz
British Journal of Pharmacology|June 2, 2018
The biomedical challenge of neurodegenerative disorders: an opportunity for cannabinoid-based therapies to improve on the poor current therapeutic outcomesJavier Fernández-Ruiz
Current Medicinal Chemistry|December 16, 2006
An overview of Parkinson's disease and the cannabinoid system and possible benefits of cannabinoid-based treatmentsIsabel Lastres-Becker, Javier Fernández-Ruiz
CNS & Neurological Disorders Drug Targets|January 29, 2008
Cannabinoids and neuroprotection in motor-related disordersEva de Lago, Javier Fernández-Ruiz
Pharmacology, Biochemistry, and Behavior|May 28, 2005
Cannabinoid tolerance and dependence: a review of studies in laboratory animalsSara González, Maribel Cebeira, Javier Fernández-Ruiz
Brain Research|February 27, 2007
The activation of cannabinoid receptors during early postnatal development reduces the expression of cell adhesion molecule L1 in the rat brainMaría Gómez, Mariluz Hernández, Javier Fernández-Ruiz
Cell Adhesion & Migration|March 6, 2009
Cannabinoid signaling system: does it play a function in cell proliferation and migration, neuritic elongation and guidance and synaptogenesis during brain ontogenesis?María Gómez, Mariluz Hernández, Javier Fernández-Ruiz
CNS Neuroscience & Therapeutics|April 22, 2010
Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disordersJavier Fernández-Ruiz, Mariluz Hernández, José A Ramos
International Review of Psychiatry (Abingdon, England)|April 16, 2009
The endocannabinoid system in neuropathological statesJosé Martínez Orgado, Javier Fernández-Ruiz, Julián Romero
Pageof 16

Showing results (1-10 of 156) with videos related to

Sort By:
Pageof 16
British Journal of Pharmacology|February 18, 2009
The endocannabinoid system as a target for the treatment of motor dysfunctionJavier Fernández-Ruiz
Revista De Neurologia|May 11, 2012
[Cannabinoid drugs for neurological diseases: what is behind?]Javier Fernández-Ruiz
British Journal of Pharmacology|June 2, 2018
The biomedical challenge of neurodegenerative disorders: an opportunity for cannabinoid-based therapies to improve on the poor current therapeutic outcomesJavier Fernández-Ruiz
Current Medicinal Chemistry|December 16, 2006
An overview of Parkinson's disease and the cannabinoid system and possible benefits of cannabinoid-based treatmentsIsabel Lastres-Becker, Javier Fernández-Ruiz
CNS & Neurological Disorders Drug Targets|January 29, 2008
Cannabinoids and neuroprotection in motor-related disordersEva de Lago, Javier Fernández-Ruiz
Pharmacology, Biochemistry, and Behavior|May 28, 2005
Cannabinoid tolerance and dependence: a review of studies in laboratory animalsSara González, Maribel Cebeira, Javier Fernández-Ruiz
Brain Research|February 27, 2007
The activation of cannabinoid receptors during early postnatal development reduces the expression of cell adhesion molecule L1 in the rat brainMaría Gómez, Mariluz Hernández, Javier Fernández-Ruiz
Cell Adhesion & Migration|March 6, 2009
Cannabinoid signaling system: does it play a function in cell proliferation and migration, neuritic elongation and guidance and synaptogenesis during brain ontogenesis?María Gómez, Mariluz Hernández, Javier Fernández-Ruiz
CNS Neuroscience & Therapeutics|April 22, 2010
Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disordersJavier Fernández-Ruiz, Mariluz Hernández, José A Ramos
International Review of Psychiatry (Abingdon, England)|April 16, 2009
The endocannabinoid system in neuropathological statesJosé Martínez Orgado, Javier Fernández-Ruiz, Julián Romero
Pageof 16